SCHEMBL21784890

SCHEMBL21784890

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc5oc6cc7c(cc6c5c4)oc4ccccc47)n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.47
▸ PLA2G4A P47712 4/20 0.47
▸ HPGD P15428 5/20 0.46
▸ MAPT P10636 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ AHR P35869 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CHEK2 O96017 1/20 0.43
▸ PLA2G10 O15496 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24318122 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL24318119 0.98 HPGD (0.47) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21019651 0.97 PLA2G2A (0.49) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21109724 0.97 PLA2G2A (0.49) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL23268144 0.97 PLA2G2A (0.49) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21109719 0.97 PLA2G2A (0.49) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21109720 0.97 PLA2G2A (0.49) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21784553 0.95 PLA2G2A (0.48) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21784565 0.95 PLA2G2A (0.48) PLA2G2APLA2G4AHPGDMAPTALDH1A1
SCHEMBL21784557 0.95 PLA2G2A (0.48) PLA2G2APLA2G4AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 — — US disclosed
WO-2020044270-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2020-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 PLA2G2A 4538/4885PLA2G4A 4679/4885HPGD 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback